CJ Bioscience (XKRX:311690) Total Liabilities : ₩19,271 Mil (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is CJ Bioscience Total Liabilities?

CJ Bioscience's Total Liabilities for the quarter that ended in Sep. 2024 was ₩19,271 Mil.

CJ Bioscience's quarterly Total Liabilities increased from Mar. 2024 (₩17,994.66 Mil) to Jun. 2024 (₩19,673.82 Mil) but then declined from Jun. 2024 (₩19,673.82 Mil) to Sep. 2024 (₩19,270.61 Mil).

CJ Bioscience's annual Total Liabilities increased from Dec. 2021 (₩28,502.16 Mil) to Dec. 2022 (₩41,733.75 Mil) but then declined from Dec. 2022 (₩41,733.75 Mil) to Dec. 2023 (₩19,632.69 Mil).

CJ Bioscience Total Liabilities Historical Data

The historical data trend for CJ Bioscience's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CJ Bioscience Total Liabilities Chart

CJ Bioscience Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

2,886.77

38,878.36

28,502.16

41,733.75

19,632.69

CJ Bioscience Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Liabilities	Get a 7-Day Free Trial															20,137.44	19,632.69	17,994.66	19,673.82	19,270.61

CJ Bioscience Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

CJ Bioscience's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	14722.469	+	(2692.382	+	2152.372
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	65.471)
	=	19,633

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	91128.386	-	71495.692
	=	19,633

CJ Bioscience's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	14226.731	+	(1537.441	+	3109.882
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	396.553)
	=	19,271

Total Liabilities	=	Total Assets (Q: Sep. 2024 )	-	Total Equity (Q: Sep. 2024 )
	=	67340.055	-	48069.448
	=	19,271

CJ Bioscience Total Liabilities Related Terms

Thank you for viewing the detailed overview of CJ Bioscience's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

CJ Bioscience Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CJ Bioscience Inc (XKRX:311690) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

7th floor, Grand Central Building B, 14 Sejong-Daero, Jung-gu, Seoul, KOR

Website

https://www.cjbioscience.com

CJ Bioscience Inc is engaged in directing a healthy life based on microbiological research. It presents directions and solutions to all fields of research on the microbiome, such as academia in the bioinformatics field, R&D centers of hospitals and research institutes, and NGS (next-generation sequencing) service companies. Its services includes NGS, EZBioCloud, Healthcare among others.

CJ Bioscience Headlines

No Headlines